← Human Trials & Peer-Reviewed Studies
The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture
Plain-language guide to PMID 16675499 (2006): randomized controlled trial of ANP (Atrial Natriuretic Peptide) in 11 subjects.
Key Facts
- PMID
- 16675499
- Journal
- Experimental physiology
- Year
- 2006
- Study type
- Randomized Controlled Trial
- Authors
- Vogelsang TW et al. (7 authors)
- DOI
- 10.1113/expphysiol.2006.033357
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of ANP (Atrial Natriuretic Peptide), published as a randomized controlled trial.
During arm exercise (A), mean arterial pressure (MAP) is higher than during leg exercise (L).
The researchers evaluated the effect of central blood volume on the MAP response to exercise by determining plasma atrial natriuretic peptide (ANP) during moderate upright and supine A, L and combined arm and leg exercise (A + L) in 11 male subjects.
Who Took Part
The abstract describes 11 subjects taking part.
By PubMed's age tags, the people studied were adults, men only.
How the Study Was Run
The design is described as randomized.
Because people in this ANP (Atrial Natriuretic Peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
The researchers evaluated the effect of central blood volume on the MAP response to exercise by determining plasma atrial natriuretic peptide (ANP) during moderate upright and supine A, L and combined arm and leg exercise (A + L) in 11 male subjects.
Topics PubMed links to this paper include Adaptation, Physiological, Arm, Atrial Natriuretic Factor, Blood Pressure, Blood Volume, Exercise Test and Leg.
What This Means in Plain Language
The paper is a randomized study of ANP (Atrial Natriuretic Peptide) in 11 subjects.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2006 (Experimental physiology), a journal based in England.
More context: the ANP (Atrial Natriuretic Peptide) compound page, all human trials.
Our Notes on the Compound
ANP (Atrial Natriuretic Peptide): A 28-amino-acid heart hormone that relaxes blood vessels and increases salt excretion; carperitide is a recombinant form.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.